Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia

NCT07169331

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Affiliated Hospital of Hebei University Baoding, Hebei, China
  • Yichang Central Peoples Hospital Yichang, Hubei, China
View Trial Details
Active, not recruiting

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

NCT05734196

Conditions
ATP-Binding Cassette Subfamily C Member 6 Deficiency, Arterial calcification of infancy, Autosomal Recessive Hypophosphatemic Rickets, +18 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Hospital Sant Joan de Déu Barcelona, Spain
View Trial Details
Active, not recruiting

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

NCT06883240

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Sacramento, California, United States
  • University of Minnesota Medical Center Minneapolis, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • UZ Leuven Gasthuisberg Leuven, Belgium
View all 26 locations
View Trial Details
Active, not recruiting

A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome

NCT03899337

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View all 17 locations
View Trial Details
Active, not recruiting

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT04747613

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center Duarte, California, United States
  • City Of Hope Duarte, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
View all 60 locations
View Trial Details
Active, not recruiting

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT00392353

Conditions
Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • North Shore University Hospital Manhasset, New York, United States
  • Mount Sinai Hospital New York, United States
View Trial Details

Related conditions